CIK: 1225199 - Address: 3000 Kent Ave., Suite A1-100, West Lafayette, IN 47906
20 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

3/3/10 19:10
3/1/10
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticGoddard ColinNYDOCEOS.d-3,64155.170-66-29158D
6/6/07 13:21
6/4/07
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticGoddard ColinNYDOCEOS.d-1,51636.980-41-3288D
8/29/06 17:43
8/25/06
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticGoddard ColinNYDOCEOS-10036.320-3-475D
8/29/06 17:41
8/25/06
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticGoddard ColinNYDOCEOS.d-98236.050-27-2678D
6/6/06 19:53
6/2/06
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticGoddard ColinNYDOCEOS.d-72330.130-24-2959
4/19/05 16:41
4/15/05
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticGoddard ColinNYDOCEOS.d-20050.000-4-939D
3/3/05 16:18
3/1/05
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticGoddard ColinNYDOCEOS.d-21653.980-4-939D
2/3/05 15:19
2/1/05
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticGoddard ColinNYDOCEOS.d-26065.120-4-939D
1/5/05 16:54
1/3/05
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticGoddard ColinNYDOCEOS.d-29673.970-4-939D
12/3/04 16:30
12/1/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticGoddard ColinNYDOCEOS.d-40148.320-8-2034D
11/2/04 19:48
11/1/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticGoddard ColinNYDOCEOS.d-53764.340-8-2034D
10/5/04 14:29
10/1/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticGoddard ColinNYDOCEOS.d-51061.090-8-2034D
9/2/04 16:59
9/1/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticGoddard ColinNYDOCEOS.d-39359.150-7-1634D
8/4/04 16:40
8/2/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticGoddard ColinNYDOCEOS.d-38858.170-7-1634D
7/2/04 16:07
7/1/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticGoddard ColinNYDOCEOS.d-46669.880-7-1634D
6/3/04 17:33
6/1/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticGoddard ColinNYDOCEOS.d-54081.270-7-1634D
5/5/04 17:18
5/3/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticGoddard ColinNYDOCEOS.d-49073.380-7-1634D
4/21/04 13:03
4/20/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticGoddard ColinNYDOCEOS.d-26740.000-7-1634D
12/22/03 18:30
12/22/03
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticGoddard ColinNYDOCEOS-30430.240-10-1274D
8/21/03 10:15
8/20/03
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticGoddard ColinNYDOCEOS-19335.000-6-3510D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact